Psoriatic Arthritis News

Secukinumab 300 mg administered with an auto-injector pen showed significant efficacy and tolerability compared with placebo, according to clinical trial results presented at the EADV Congress virtual meeting.

Oligoarticular disease occurs in 47% of patients with psoriatic arthritis and presents similarly to polyarticular disease, often affecting small joints of the hands and feet, according to data published in The Journal of Rheumatology.

Patients with immune mediated inflammatory diseases are tested for COVID-19 at a 20% higher rate than the general population, according to data published in Arthritis Care & Research.

A reminder of some common and not-so-common clinical scenarios can make every rheumatologist more capable of delivering optimal patient care, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

Clearly defining treatment targets and communicating those targets to patients is essential to optimizing outcomes in psoriatic arthritis, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

COVID-19 mortality was not increased in patients on immunosuppressive biologics, according to a study.

Patients with rheumatic diseases who were pregnant at the time of developing COVID-19 demonstrated favorable pregnancy and infection outcomes, according to data published in The Journal of Rheumatology.

The National Psoriasis Foundation COVID-19 Task Force is recommending booster doses of mRNA COVID-19 vaccines for some patients with psoriatic disease.

Patients with psoriasis who received biologic drugs demonstrated a lower risk — that was statistically and clinically significant — for developing psoriatic arthritis, according to data published in Arthritis & Rheumatology.

Male patients diagnosed with inflammatory arthritis at or before peak reproductive age have a lower fertility rate, a higher childlessness rate, and more fertility issues, according to data published in the Annals of the Rheumatic Diseases.